Jefferies Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $80
Jefferies Initiates Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Announces Target Price $80
Rhythm Pharmaceuticals Initiated With a Buy at Jefferies
Rhythm Pharmaceuticals Price Target Maintained With a $69.00/Share by HC Wainwright & Co.
JMP Securities Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $75
Strategic Advancements and Market Potential Drive Buy Rating for Rhythm Pharmaceuticals
